Literature DB >> 18728159

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.

Thomas Reinehr1, Christian L Roth.   

Abstract

CONTEXT: There are very limited data available concerning the relationships between fetuin-A, weight status, nonalcoholic fatty liver disease (NAFLD), and features of the metabolic syndrome (MetS) in obese humans, and especially in children.
OBJECTIVE: Our objective was to study the longitudinal relationships between fetuin-A, NAFLD, and MetS in obese children.
DESIGN: This was a 1-yr longitudinal follow-up study.
SETTING: This study was performed in primary care. PATIENTS: A total of 36 obese and 14 lean children was included in the study. INTERVENTION: An outpatient 1-yr intervention program based on exercise, behavior, and nutrition therapy was performed. MAIN OUTCOME MEASURES: Changes of weight status (sd score-body mass index), waist circumference, fetuin-A, blood pressure, lipids, transaminases, insulin resistance index homeostasis model assessment (HOMA), and prevalence of NAFLD (defined by liver ultrasound) were calculated.
RESULTS: The 12 obese children with NAFLD had significantly higher fetuin-A levels (0.35+/-0.07 g/liter) than the 24 obese children without NAFLD (0.29+/-0.06 g/liter) and the 14 normal weight children (0.29+/-0.05 g/liter). Fetuin-A levels were independent of age, pubertal stage, and gender. Fetuin-A correlated significantly to systolic (r=0.50) and diastolic blood pressure (r=0.41), insulin resistance index HOMA (r=0.28), and high-density lipoprotein-cholesterol (r=-0.31). Changes of fetuin-A correlated significantly to changes of insulin resistance index HOMA (r=0.34), systolic (r=0.31) and diastolic blood pressure (r=0.37), and waist circumferences (r=0.36). Substantial weight loss in 21 children led to a significant decrease of fetuin-A and the prevalence of NAFLD in contrast to the 15 children without substantial weight loss.
CONCLUSIONS: Fetuin-A levels were higher in children with NAFLD, and were related to insulin resistance and to features of the MetS in both cross-sectional and longitudinal analyses. Therefore, fetuin-A might be a new promising link between obesity and its comorbidities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728159     DOI: 10.1210/jc.2008-1505

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  73 in total

Review 1.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults.

Authors:  T Filardi; F Panimolle; C Tiberti; C Crescioli; A Lenzi; N Pallotta; S Morano
Journal:  J Endocrinol Invest       Date:  2020-04-30       Impact factor: 4.256

3.  Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.

Authors:  Po-Jen Yang; Kong-Han Ser; Ming-Tsan Lin; Hsiao-Ching Nien; Chiung-Nien Chen; Wei-Shiung Yang; Wei-Jei Lee
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

4.  Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity.

Authors:  Steven K Malin; Juan Pablo del Rincon; Hazel Huang; John P Kirwan
Journal:  Med Sci Sports Exerc       Date:  2014-11       Impact factor: 5.411

Review 5.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

Review 6.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 7.  Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance.

Authors:  Thomas Reinehr
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 8.  The role of hepatokines in metabolism.

Authors:  Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Endocrinol       Date:  2013-01-22       Impact factor: 43.330

Review 9.  Advances in pediatric nonalcoholic fatty liver disease.

Authors:  Rohit Loomba; Claude B Sirlin; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes.

Authors:  Luis H Eraso; Naeema Ginwala; Atif N Qasim; Nehal N Mehta; Rachel Dlugash; Shiv Kapoor; Stanley Schwartz; Mark Schutta; Nayyar Iqbal; Emile R Mohler; Muredach P Reilly
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.